Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Forde

Showing results (151-160 of 307) with videos related to

Pageof 31
Sort By:
ACS Nano|December 18, 2013
High activity redox catalysts synthesized by chemical vapor impregnationMichael M Forde, Lokesh Kesavan, Mohd Izham Bin Saiman, et al.
Journal for Immunotherapy of Cancer|October 12, 2018
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case seriesKendall F Moseley, Jarushka Naidoo, Clifton O Bingham, et al.
JAMA Network Open|April 17, 2024
Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung CancerMelinda L Hsu, Mary C Boulanger, Sarah Olson, et al.
Annals of the Rheumatic Diseases|September 22, 2019
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessationTawnie J Braaten, Julie R Brahmer, Patrick M Forde, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 11, 2020
The clinical presentation, treatment and outcome of serologically confirmed paediatric Lyme disease in the Republic of Ireland over a 5-year period: a retrospective cohort studyKarina M Forde, Joanne O'Gorman, Patrick J Gavin, et al.
Non-Coding RNA Research|March 17, 2025
PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapyAndrei Gurau, Suguru Yamauchi, Kaitlyn Ecoff, et al.
Plos One|August 16, 2014
The complete genome sequence of Escherichia coli EC958: a high quality reference sequence for the globally disseminated multidrug resistant E. coli O25b:H4-ST131 cloneBrian M Forde, Nouri L Ben Zakour, Mitchell Stanton-Cook, et al.
The Oncologist|March 1, 2018
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung CancerKristen A Marrone, Xian Zhou, Patrick M Forde, et al.
Nature Reviews. Clinical Oncology|July 24, 2023
Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challengesGiannis Mountzios, Jordi Remon, Lizza E L Hendriks, et al.
Journal of Clinical Microbiology|October 31, 2022
Optimized Method for Bacterial Nucleic Acid Extraction from Positive Blood Culture Broth for Whole-Genome Sequencing, Resistance Phenotype Prediction, and Downstream Molecular ApplicationsMichelle J Bauer, Anna Maria Peri, Lukas Lüftinger, et al.
Pageof 31

Showing results (151-160 of 307) with videos related to

Sort By:
Pageof 31
ACS Nano|December 18, 2013
High activity redox catalysts synthesized by chemical vapor impregnationMichael M Forde, Lokesh Kesavan, Mohd Izham Bin Saiman, et al.
Journal for Immunotherapy of Cancer|October 12, 2018
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case seriesKendall F Moseley, Jarushka Naidoo, Clifton O Bingham, et al.
JAMA Network Open|April 17, 2024
Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung CancerMelinda L Hsu, Mary C Boulanger, Sarah Olson, et al.
Annals of the Rheumatic Diseases|September 22, 2019
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessationTawnie J Braaten, Julie R Brahmer, Patrick M Forde, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 11, 2020
The clinical presentation, treatment and outcome of serologically confirmed paediatric Lyme disease in the Republic of Ireland over a 5-year period: a retrospective cohort studyKarina M Forde, Joanne O'Gorman, Patrick J Gavin, et al.
Non-Coding RNA Research|March 17, 2025
PD-L1 pfeRNAs as blood-based predictors of treatment response of unresectable malignant pleural mesothelioma patients administered Durvalumab with cisplatin and pemetrexed as first-line therapyAndrei Gurau, Suguru Yamauchi, Kaitlyn Ecoff, et al.
Plos One|August 16, 2014
The complete genome sequence of Escherichia coli EC958: a high quality reference sequence for the globally disseminated multidrug resistant E. coli O25b:H4-ST131 cloneBrian M Forde, Nouri L Ben Zakour, Mitchell Stanton-Cook, et al.
The Oncologist|March 1, 2018
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung CancerKristen A Marrone, Xian Zhou, Patrick M Forde, et al.
Nature Reviews. Clinical Oncology|July 24, 2023
Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challengesGiannis Mountzios, Jordi Remon, Lizza E L Hendriks, et al.
Journal of Clinical Microbiology|October 31, 2022
Optimized Method for Bacterial Nucleic Acid Extraction from Positive Blood Culture Broth for Whole-Genome Sequencing, Resistance Phenotype Prediction, and Downstream Molecular ApplicationsMichelle J Bauer, Anna Maria Peri, Lukas Lüftinger, et al.
Pageof 31